BeyondSpring Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (4)

Latest Posts

About This Stock More About This Stock
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today
Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Read
Week In Review: China Resources Pharma Files For $369 Million China Life Science Investment Fund
Article By: ChinaBio® Today
Saturday, October 28, 2017 5:31 PM EST
China Resources Pharmaceutical (HK: 3320) filed with the Hong Kong exchange to raise $368.5 million in an investment fund. The fund will be run by its subsidiary, CR Pharm (Shantou). It will make equity investments in China pharma companies.
In this article: HCM, BYSI
Read
Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal
Article By: ChinaBio® Today
Saturday, July 8, 2017 2:35 PM EST
BeiGene of Beijing has entered a "transformational" collaboration with Celgene which involves BeiGene's clinical-stage PD-1 immuno-oncology drug, has a total value of almost $1.4 billion.
In this article: CELG, QGEN, BGNE, BYSI, ATNX
Read
Week In Review: Fosun Eyeing $4 Billion Bid For Germany's Stada Pharma
Article By: ChinaBio® Today
Saturday, March 11, 2017 1:52 PM EST
Shanghai Fosun Pharma is said to be contemplating a bid for Germany's Stada Arzneimittel, a well established generic drug company.
In this article: BGNE, BYSI
Read

PARTNER HEADLINES

Latest Tweets for $BYSI

No tweets yet!